Search
    ×

    Press releases

    Advanced Search
    • Jul 29, 2021

      BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that management will be presenting at the UBS Genomics 2.0 and MedTech Innovations...

    • Jul 29, 2021

      BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the company will begin remediation for the February 4, 2020 BD Alaris™ System1 recall...

    • Jul 27, 2021

      The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.83 per common share, payable on September 30, 2021 to holders of record on...

    • Jul 27, 2021

      BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired Tepha, Inc., a leading developer and manufacturer of a proprietary...

    • Jul 20, 2021
      Acquisition of Velano Vascular Adds Innovative Needle-Free Blood Draw Technology to Reduce Pain and Discomfort of Multiple Needlesticks

      BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has taken a large step forward in transforming the patient experience through a...

    • Jul 19, 2021
      BD, Heart to Heart International and the NAFC Announce 2020/2021 Grantees for Multi-YearDiagnostic Testing Initiative to Improve Patient Outcomes

      Alexandria, VA, July 19, 2021 (GLOBE NEWSWIRE) -- As part of a continued effort to support and improve evidence-based care in free and charitable clinics, BD (Becton, Dickinson and Company) (NYSE:...

    • Jul 12, 2021
      David F. Melcher to be non-executive chair; Claire Pomeroy, MD, MBA, to be a director

      BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that David F. Melcher will be non-executive chair of the board of directors, and Claire...

    • Jul 7, 2021
      New online portal effectively aggregates, customizes and streamlines purchasing of essential reagents to accelerate bold research and clinical innovation

      BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of a new bdbiosciences.com web and eCommerce site, an entirely...

    • Jun 30, 2021
      BD also announced plans to host an Investor Day

      BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report its financial results for the third quarter of fiscal year 2021 on Thursday, August 5, 2021. BD will issue a press...

    • Jun 23, 2021
      PeritX™ Peritoneal Catheter System is the first and only at-home system indicated for malignant and non-malignant ascites drainage in the United States.

      BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for...

    Show 5102550100 per page